ArticleThe Journal of clinical endocrinology and metabolism2026
Heart ventricular function in hospitalized patients with severe hypothyroidism and myxedema coma.
Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
contextThe clinical relevance of thyroid hormone-mediated inotropic effects in humans remains uncertain.
objectiveWe evaluated ventricular function in patients with severe hypothyroidism and myxedema coma using transthoracic echocardiography and speckle-tracking echocardiography.
methodsMulticenter, retrospective cross-sectional study of adults admitted to intensive care units with severe hypothyroidism who underwent transthoracic echocardiography during hospitalization. Left ventricular (LV) systolic and diastolic function and myocardial deformation, assessed by global longitudinal strain (GLS), were analyzed.
resultsOne hundred and twelve patients were included (mean age 53.9 ± 13.7 years; 64.3% female). Myxedema coma was present in 33 patients (29.5%), and 13 (11.6%) had severe hypothyroidism with altered mental status without hypothermia or bradycardia. Median admission thyroid-stimulating hormone was 113.9 (41.9-500.0) mIU/L. The mean LV ejection fraction (LVEF) was 53.9 ± 13.7%, LV GLS -13.5 ± 4.2% (reference -24% to -16%), and right ventricular (RV) GLS -17.9 ± 6% (reference -35% to -17%). Reduced LVEF occurred in 37.5% of patients, abnormal LV diastolic function in 66.7%, and impaired LV and RV GLS in 68.2% and 34.0%, respectively. In multivariable models, β-blocker treatment was associated with lower LVEF and worse biventricular GLS; angiotensin-converting enzyme inhibitor/angiotensin receptor blocker treatment with lower LVEF; and calcium channel blocker exposure was associated with improved RV GLS. In-hospital mortality was 4.5% and occurred in patients with preserved LVEF.
conclusionSevere hypothyroidism is associated with frequent systolic and diastolic ventricular dysfunction and prevalent impairment of myocardial deformation. Associations between cardiovascular medication exposure and echocardiographic abnormalities likely reflect confounding by indication and underlying clinical phenotype rather than reflecting causal drug effects. Despite substantial myocardial abnormalities, short-term mortality was low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.